By moving beyond adherence and drug interactions to a holistic, outcomes-driven approach, health systems and providers can redefine how medication is used — not as a rigid protocol but as a dynamic, patient-centered tool for achieving better health.
As we all work to wrap up the year and enter into 2025, here are a few trends to keep your eye on in the coming months and beyond.
See how Quantum Health is providing the steps to help their members tackle the cost of specialty medications and other drugs.
To realize true, sustainable savings in total cost of care, the healthcare system needs to reconsider the support — or lack of support — it provides throughout patients’ medication experiences and the snowball effect that creates on a lifetime of healthcare costs.
The dangers of polypharmacy and its increasingly wide reach across the American population make it imperative that we enhance the accuracy and efficiency of medication reconciliation processes.
Researchers recently tested ChatGPT’s ability to answer patient questions about medication, finding that the AI model gave wrong or incomplete answers about 75% of the time. Providers should be wary of the fact that the model does not always give sound medical advice, given many of their patients could be turning to ChatGPT to answer health-related questions.
This article explores the benefits of implementing RFID in healthcare settings and how hospitals can gradually transition from barcode to RFID-enabled medication systems, leading to substantial cost savings and improved patient care.
The ongoing nursing shortage facilitates high turnover rates since nurses know they won’t have difficulties finding new jobs. In order to retain and attract staff, it’s in a facility’s best interest to understand what nurses want.
Lyfegen, a startup that provides software for value-based drug contracting, recently raised $8 million in an oversubscribed Series A financing round. With the new funds, the company — which is based in Switzerland and New York — plans to expand its presence in the U.S., where drug costs are the highest in the world.
Shkreli controversially raised the price of the drug Daraprim, which is used to treat a potentially fatal parasitic infection, by 4,000%, from $13.50 to $750 per pill in 2015. In January, a federal judge banned him from the pharmaceutical industry for life.
A new partnership between Amazon and First Databank will let users ask Alexa for basic information about the most commonly prescribed drugs.
Through its app, London-based Echo, which was founded in 2015, offers prescription fulfillment and reminders to take medications.
Help shape the future of healthcare benefits by sharing your insights.
Various investors, including Stanley Black & Decker's corporate venture capital arm, Samsung Ventures, Civilization Ventures and others took part in the round.
The Clearwater, Florida-based company said its HIPAA compliant telemedicine stations can be deployed in airports, hotels, colleges, hospitals and at large private employers.
Zola Global and Greenoaks Capital led the Series C round, and Jackson Square Ventures, Olive Tree Capital, and others participated.
The company will use the money to increase its pharmaceutical and pharmacy partnerships, expand into more healthcare verticals and enhance its data analysis and engineering applications.
The company's Individual Risk Identification Score, or IRIS, uses machine learning to help hospitals pinpoint employees who pose a high risk for drug diversion.